Hemophilia A Global Clinical Trials Review, H2, 2016 - GlobalData

Hemophilia A Global Clinical Trials Review, H2, 2016

Hemophilia A Global Clinical Trials Review, H2, 2016 - GlobalData
Hemophilia A Global Clinical Trials Review, H2, 2016
Published Aug 31, 2016
228 pages — Published Aug 31, 2016
Price US$ 2,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GlobalData's clinical trial report, Hemophilia A Global Clinical Trials Review, H2, 2016' provides an overview of Hemophilia A clinical trials scenario. This report provides top line data relating to the clinical trials on Hemophilia A. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

  
Source:
Document ID
GDHC3713CTIDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Report Guidance51
Clinical Trials by Region69
  Clinical Trials and Average Enrollment by Country73
    Top Five Countries Contributing to Clinical Trials in Asia-Pacific101
    Top Five Countries Contributing to Clinical Trials in Europe111
    Top Countries Contributing to Clinical Trials in North America121
    Top Five Countries Contributing to Clinical Trials in Middle East and Africa131
    Top Five Countries Contributing to Clinical Trials in Central and South America141
Clinical Trials by G7 Countries: Proportion of Hemophilia A to Hematological Disorders Clinical Trials151
Clinical Trials by Phase in G7 Countries161
Clinical Trials in G7 Countries by Trial Status171
Clinical Trials by E7 Countries: Proportion of Hemophilia A to Hematological Disorders Clinical Trials181
Clinical Trials by Phase in E7 Countries191
Clinical Trials in E7 Countries by Trial Status201
Clinical Trials by Phase212
  In Progress Trials by Phase221
Clinical Trials by Trial Status231
Clinical Trials by End Point Status241
Subjects Recruited Over a Period of Time251
Clinical Trials by Sponsor Type261
Prominent Sponsors273
  Top Companies Participating in Hemophilia A Therapeutics Clinical Trials282
Prominent Drugs301
Latest Clinical Trials News on Hemophilia A318
  Jul 27, 2016: CSL Behring Presents Pivotal Efficacy Data for AFSTYLA In Adolescents and Children with Hemophilia A at the World Federation of Hemophilia 2016 World Congress311
  Jul 26, 2016: Sangamo BioSciences Announces New Gene Therapy Clinical Development Program for Treatment Of Hemophilia A321
  Jul 26, 2016: ADYNOVATE Phase 3 Efficacy and Safety Data in Children to be Showcased During International Congress of the World Federation of Hemophilia322
  Jul 26, 2016: SIPPET Study was WFH 2016 World Congress Highlight341
  Jul 25, 2016: Alnylam Announces New Positive Interim Phase 1 Study Results for Fitusiran, a Once-Monthly, Subcutaneous, Investigational RNAi Therapeutic Targeting Antithrombin for the Treatment of Hemophilia and Rare Bleeding Disorders342
  Jul 25, 2016: Alnylam to Report New Clinical Results with Fitusiran at the World Federation of Hemophilia 2016 World Congress361
  Jul 19, 2016: CSL Behring to Present New Data for AFSTYLA at the World Federation of Hemophilia 2016 World Congress361
  Jul 19, 2016: Shire reinforces commitment in Hematology with robust data presented at international congress of the World Federation of Hemophilia371
  Jul 18, 2016: Biogen and Sobi to Showcase Long-Term Efficacy and Safety Data on ELOCTATE at World Federation of Hemophilia 2016 World Congress371
  Jul 18, 2016: Biogen and Sobi to Showcase Data on FVIIIFc-VWF-XTEN at World Federation of Hemophilia 2016 World Congress381
Clinical Trial Profile Snapshots39186
Appendix2254
  Abbreviations2251
  Definitions2251
  Research Methodology2261
  Secondary Research2261
  About GlobalData2271
  Contact Us2271
  Disclaimer2271
  Source2281

Table Of Contents

GlobalData—GlobalData uses proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries.

About the Author


Cite this Report

  
MLA:
GlobalData. "Hemophilia A Global Clinical Trials Review, H2, 2016" Aug 31, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData/Hemophilia-A-Global-Clinical-Trials-Review-H2-2016-2085-23711>
  
APA:
GlobalData. (2016). Hemophilia A Global Clinical Trials Review, H2, 2016 Aug 31, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData/Hemophilia-A-Global-Clinical-Trials-Review-H2-2016-2085-23711>
  
US$ 2,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.